Pregnant people are routinely offered blood-based, cell-free (cf) DNA sequencing to screen for fetal abnormalities. Unexpected findings may be a result of tumor DNA in the maternal blood sample ...

Researchers at the National Institutes of Health (NIH) found previously undetected cancers in 48.6% of pregnant people who had abnormal results for prenatal cell-free DNA (cfDNA) testing used to ...

Recently, the introduction of “cell-free fetal ... result on this screening, the chance of a baby with a chromosomal abnormality is about 1 in 90,000. False positives on this test are also ...

Mercy is offering a new, revolutionary cancer screening that can detect around fifty types of cancer even earlier with a ...

Diana Bianchi is from the National Human Genome Research Institute at the NIH in Bethesda, Maryland. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal.

Her writing focuses on gene editing technology, cell and gene therapies, and the regulatory space.

et al. Direct detection and quantification of bacterial cell-free DNA in patients with bloodstream infection (BSI) using the Karius plasma next generation sequencing (NGS) test. Open Forum Infect.

Upper tract urothelial carcinoma (UTUC) is an aggressive disease that is challenging to biopsy and diagnose, frequently yielding nondiagnostic cytology and tissue specimens. Therefore, UTUC is often ...

Aldevron's proprietary cell-free DNA manufacturing process, utilizing rolling circle amplification, enables the rapid production of linear DNA templates. This method supports the swift screening ...

Keep abreast with the latest news related to Cell-Free DNA (cfDNA) Application in Cancer Detect there are 68 news items on Cell-Free DNA (cfDNA) Application in Cancer Detect that covers updates ...

Aldevron’s Alchemy™ is an exclusive cell-free DNA technology which cuts research grade linear DNA manufacturing time by over 50 percent, accelerating mRNA development projects with cleaner ...